Jeffrey Vacirca, MD, FACP is a board certified hematologist and oncologist at New York Cancer & Blood Specialists, where he serves as CEO and managing partner. His specialties include breast cancer, prostate cancer, and complicated cancers. Currently, Dr. Vacirca is the president of the Community Oncology Alliance (COA), medical director for Amerisource Bergen specialty group, a Scientific Advisory Board Member for Caris Life Sciences, president and co-founder of National Translational Research Group, and serves as a medical board advisor for Flatiron Health, located in New York City. Additionally, he is the vice-chairmen of the board for Odonate Therapeutics, a company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. He has been the recipient of the Theodore Roosevelt award for outstanding dedication to patient care and has been named in Newsday's Top Doctors.